ACCC all gassed up and ready to go!
24 August 2012
Things are heating up for two Australian gas supply companies who are in cartel hot water
Read on
All Mallesons Pulse Posts
All Mallesons Pulse Posts
Are genes patentable? US Court of Appeals says “yes” for the second time
22 August 2012
In March this year, the US Court of Appeals was ordered by the US Supreme Court to reconsider its decision in Association for Molecular Pathology v Myriad Genetics (see our previous post).
Read on
No longer blowing in the wind – US senate offers protection for antitrust informers
21 August 2012
On 31st July 2012 the Criminal Antitrust Anti-Retaliation Act was introduced to the US Congress by Senators Patrick Leahy and Chuck Grassley.
Read on
Copyright and the Digital Economy – Issues Paper released by ALRC
20 August 2012
The Australian Law Reform Commission (ALRC) today released the Issues Paper for its current enquiry into copyright and the digital economy.
Read on
Facebook’s billion dollar baby
16 August 2012
The reasonably new “market” that is social networking has seen its first headline-making acquisition cleared by the UK OFT.
Read on
Beastie Boys fight… for their right… by suing Monster Energy Drink
16 August 2012
Following the death of founding Beastie Boys member, Adam Yaunch, the remaining Beastie Boys and Yaunch’s estate are suing Monster Energy Drink for using the band’s songs without permission and suggesting an endorsement that Beastie Boys had not given.
Read on
Def Leppard fire silver bullet in copyright stand-off
15 August 2012
Def Leppard and their record company, Universal, have once again proved that musicians and music labels go together like oil and water.
Read on
Google faces further scrutiny in India
14 August 2012
Emerging markets, emerging problems - Google faces further antitrust scrutiny in India
Read on
Belts and braces
14 August 2012
After conducting dawn raids in the wire harnesses sector in February 2010, the European Commission has now opened a formal investigation.
Read on
European Commission ups the cost of paying for delay
13 August 2012
On 25 July 2012, the EC alleged that Danish pharmaceutical company Lundbeck violated EU antitrust rules by colluding to prevent other pharma companies from marketing generic versions of its best-seller antidepressant, citalopram.
Read on
Load More Posts